Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Transcure benchmarks aim for 99%+ first-pass acceptance through AI-powered claim scrubbing
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
The safety, quality, and clinical support behind it do not compare
Some clinical studies have measured improvements in skin firmness of 20% to 30% after just 12 weeks of consistent use
Those with certain genetic variations affecting b12 metabolism may benefit from methylcobalamin specifically
US$ 24.18
US$ 24.25
US$ 20.85
US$ 26.24
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
